• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

Roche

Posted inAutoimmune Diseases, Neuroscience, New Drugs, Regulatory

Kesimpta: Highly Effective New Drug for Multiple Sclerosis

by Julia Mardi June 4, 2021September 8, 2022

Ofatumumab by Novartis is as good and convenient as Ocrevus by Roche against multiple sclerosis.

Posted inPharma & Biotech

Halozyme: Elegant Transformation of Drugs From Intravenous to Subcutaneous

by Timur Burkhanayev April 14, 2021September 8, 2022

Easy and quick administration of biological drugs. All for the convenience of patient care.

Posted inNeuroscience, New Drugs, Rare/Orphan Diseases, Regulatory

Zolgensma: Gene Therapy That Cure Spinal Muscular Atrophy. The Most Comprehensive Review

by Tanya von Reuss, Mark Gubar, Alex Avisoni and Nik Resovski April 8, 2021September 8, 2022

Novartis revealed the most expensive drug in the world. And it is amazing.

Lungs.
Posted inClinical Trials, In the Pipeline, Oncology, Regulatory

Small Cell Lung Cancer: Let Immunotherapy Help!

by Tanya von Reuss and Timur Burkhanayev April 3, 2021September 8, 2022

A deadly disease and modern pharmacological attempts to treat it.

Pills.
Posted inOncology, Research

Not All Cancer Drugs Are Equally Useful

by Alex Avisoni April 3, 2021September 8, 2022

Cheating out of ignorance, or Sleight of hand and no fraud. How pharmaceutical companies scam clinical trials.

Posted inNew Drugs, Oncology, Regulatory

Enhertu: Most Powerful Drug to Treat Advanced HER2-Positive Breast Cancer

by Mark Gubar March 31, 2021September 8, 2022

Trastuzumab deruxtecan, developed by AstraZeneca and Daiichi Sankyo, will save lives when Herceptin, Perjeta, and Kadcyla haven’t worked.

Posts pagination

Newer posts 1 2 3
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×